Related Experiment Video
Updated: Jan 28, 2026

MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria
Published on: February 23, 2021
MS2 Labeling of Endogenous Beta-Actin mRNA Does Not Result in Stabilization of Degradation Intermediates
Songhee H Kim1,2, Melissa Vieira2,3, Hye-Jin Kim2
1Department of Physics and Astronomy, Seoul National University, Seoul 08826, Korea.
Abstract:
The binding of MS2 bacteriophage coat protein (MCP) to MS2 binding site (MBS) RNA stem-loop sequences has been widely used to label mRNA for live-cell imaging at single-molecule resolution. However, concerns have been raised recently from studies with budding yeast showing aberrant mRNA metabolism following the MS2-GFP labeling. To investigate the degradation pattern of MS2-GFP-labeled mRNA in mammalian cells and tissues, we used Northern blot analysis of β-actin mRNA extracted from the Actb-MBS knock-in and MBS×MCP hybrid mouse models. In the immortalized mouse embryonic cell lines and various organ tissues derived from the mouse models, we found no noticeable accumulation of decay products of β-actin mRNA compared with the wild-type mice. Our results suggest that accumulation of MBS RNA decay fragments does not always happen depending on the mRNA species and the model organisms used.
Insights
MS2-GFP labeling of mRNA for live-cell imaging does not cause aberrant mRNA metabolism in mammalian cells. Studies found no significant accumulation of decay products in mouse models, suggesting context-dependent effects.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- MS2 bacteriophage coat protein (MCP) binding to MS2 binding site (MBS) RNA is a common method for mRNA labeling in live-cell imaging.
- Recent studies in yeast suggest potential aberrant mRNA metabolism following MS2-GFP labeling.
Purpose of the Study:
- To investigate the degradation patterns of MS2-GFP-labeled mRNA in mammalian cells and tissues.
- To determine if aberrant mRNA metabolism observed in yeast occurs in mammalian systems.
Main Methods:
- Utilized Northern blot analysis to examine β-actin mRNA decay products.
- Employed Actb-MBS knock-in and MBS×MCP hybrid mouse models for in vivo studies.
- Analyzed immortalized mouse embryonic cell lines and various organ tissues.
Main Results:
- No noticeable accumulation of β-actin mRNA decay products was observed in labeled cells and tissues compared to wild-type controls.
- The findings indicate that MS2-GFP labeling does not consistently lead to mRNA degradation fragments in mammalian models.
Conclusions:
- The accumulation of MBS RNA decay fragments is not a universal outcome of MS2-GFP labeling.
- Degradation patterns appear to be dependent on specific mRNA species and the model organisms utilized.
Related Concept Videos
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
RNA Stability
Nuclear Export of mRNA
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...

